Trials / Recruiting
RecruitingNCT05016908
Extracellular RNA Biomarkers of Duchenne Muscular Dystrophy
- Status
- Recruiting
- Phase
- —
- Study type
- Observational
- Enrollment
- 100 (estimated)
- Sponsor
- Massachusetts General Hospital · Academic / Other
- Sex
- All
- Age
- 5 Years
- Healthy volunteers
- —
Summary
Current methods of measuring the response to new treatments for muscular dystrophies involve the examination of small pieces of muscle tissue called biopsies. The investigators are interested in finding less invasive methods that reduce the need for muscle biopsies. The purpose of this research is to learn about the possibility of detecting and measuring the activity and severity of muscular dystrophies by examining a urine sample and a blood sample.
Conditions
Timeline
- Start date
- 2019-11-30
- Primary completion
- 2026-11-01
- Completion
- 2027-11-01
- First posted
- 2021-08-23
- Last updated
- 2025-11-24
Locations
2 sites across 1 country: United States
Source: ClinicalTrials.gov record NCT05016908. Inclusion in this directory is not an endorsement.